{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:19:37Z","timestamp":1773231577294,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ajg.2024.11.002","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T06:11:36Z","timestamp":1736057496000},"page":"67-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical features and temporal trends in H. pylori negative gastric maltoma"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8882-3635","authenticated-orcid":false,"given":"Ali","family":"Hajj Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Ali","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Alrazim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"Shaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajg.2024.11.002_b0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3748\/wjg.v17.i6.697","article-title":"Primary gastrointestinal lymphoma","volume":"17","author":"Ghimire","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2024.11.002_b0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.25122\/jml-2018-0035","article-title":"MALT lymphoma: epidemiology, clinical diagnosis and treatment","volume":"11","author":"Violeta Filip","year":"2018","journal-title":"J Med Life"},{"issue":"11","key":"10.1016\/j.ajg.2024.11.002_b0015","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/1097-0142(19831201)52:11<2044::AID-CNCR2820521113>3.0.CO;2-5","article-title":"Primary gastric lymphoma. An analysis with emphasis on prognostic factors and radiation therapy","volume":"52","author":"Shimm","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ajg.2024.11.002_b0020","series-title":"Marginal zone B-cell lymphomas","article-title":"Marginal zone B-cell lymphomas","author":"Zinzani","year":"2017"},{"issue":"1","key":"10.1016\/j.ajg.2024.11.002_b0025","first-page":"27","article-title":"Gastric MALT lymphoma: old and new insights","volume":"27","author":"Zullo","year":"2014","journal-title":"Ann Gastroenterol"},{"issue":"Suppl 3","key":"10.1016\/j.ajg.2024.11.002_b0030","article-title":"Helicobacter and gastric MALT lymphoma","volume":"50","author":"Stolte","year":"2002","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ajg.2024.11.002_b0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12032-009-9207-y","article-title":"Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis","volume":"27","author":"Zullo","year":"2010","journal-title":"Med Oncol Northwood Lond Engl"},{"issue":"10","key":"10.1016\/j.ajg.2024.11.002_b0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MCG.0b013e318286ff72","article-title":"Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review","volume":"47","author":"Zullo","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.ajg.2024.11.002_b0045","doi-asserted-by":"crossref","first-page":"706","DOI":"10.5009\/gnl15510","article-title":"Helicobacter pylori eradication therapy is effective as the initial treatment for patients with H. pylori-negative and disseminated gastric mucosa-associated lymphoid tissue lymphoma","volume":"10","author":"Gong","year":"2016","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.ajg.2024.11.002_b0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5009\/gnl.2014.8.4.408","article-title":"Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma according to Helicobacter pylori infection status: a single-center experience","volume":"8","author":"Ryu","year":"2014","journal-title":"Gut Liver"},{"issue":"6","key":"10.1016\/j.ajg.2024.11.002_b0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","article-title":"EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT","volume":"60","author":"Ruskon\u00e9-Fourmestraux","year":"2011","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ajg.2024.11.002_b0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/hel.12033","article-title":"Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome","volume":"18","author":"Choi","year":"2013","journal-title":"Helicobacter"},{"issue":"6","key":"10.1016\/j.ajg.2024.11.002_b0065","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00277-014-2298-3","article-title":"Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up","volume":"94","author":"Raderer","year":"2015","journal-title":"Ann Hematol"},{"issue":"18","key":"10.1016\/j.ajg.2024.11.002_b0070","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.3748\/wjg.v20.i18.5191","article-title":"History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer","volume":"20","author":"Graham","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"Suppl 6","key":"10.1016\/j.ajg.2024.11.002_b0075","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Zucca","year":"2013","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"9","key":"10.1016\/j.ajg.2024.11.002_b0080","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","article-title":"Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications","volume":"18","author":"Tshibangu-Kabamba","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ajg.2024.11.002_b0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0924-8579(01)00482-4","article-title":"Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon","volume":"19","author":"Sharara","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajg.2024.11.002_b0090","doi-asserted-by":"crossref","unstructured":"Osman M, Rafei R, Cummings K, Rafei W, Awada J, Moubayed H. Initial data on Helicobacter pylori resistance in Lebanon. Access Microbiol [Internet]. 2023 Jan 23; Available from: https:\/\/doi.org\/10.1099\/acmi.0.000564.v1.","DOI":"10.1099\/acmi.0.000564.v1"},{"key":"10.1016\/j.ajg.2024.11.002_b0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.micpath.2018.02.010","article-title":"First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy","volume":"117","author":"Tarhini","year":"2018","journal-title":"Microb Pathog"},{"issue":"3","key":"10.1016\/j.ajg.2024.11.002_b0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.4852","article-title":"The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)","volume":"241","author":"Kuo","year":"2017","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.ajg.2024.11.002_b0105","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/cancers15041206","article-title":"Comprehensive analysis of gene expression profiling to explore predictive markers for eradication therapy efficacy against Helicobacter pylori-negative gastric MALT lymphoma","volume":"15","author":"Takigawa","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ajg.2024.11.002_b0110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"Thieblemont","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ajg.2024.11.002_b0115","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/annonc\/mdn760","article-title":"Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type","volume":"20","author":"Stathis","year":"2009","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"6","key":"10.1016\/j.ajg.2024.11.002_b0120","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1002\/ajh.25447","article-title":"Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma","volume":"94","author":"Strati","year":"2019","journal-title":"Am J Hematol"},{"issue":"26","key":"10.1016\/j.ajg.2024.11.002_b0125","doi-asserted-by":"crossref","first-page":"8014","DOI":"10.3748\/wjg.v21.i26.8014","article-title":"Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review","volume":"21","author":"Asano","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"17","key":"10.1016\/j.ajg.2024.11.002_b0130","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3748\/wjg.v16.i17.2158","article-title":"Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma","volume":"16","author":"Park","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.ajg.2024.11.002_b0135","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/CM9.0000000000000813","article-title":"Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis","volume":"133","author":"Xie","year":"2020","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"10.1016\/j.ajg.2024.11.002_b0140","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/path.1593","article-title":"Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of \u201cHelicobacter heilmannii\u201d infection","volume":"203","author":"O\u2019Rourke","year":"2004","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.ajg.2024.11.002_b0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2169\/internalmedicine.8971-17","article-title":"The resolution of helicobacter suis-associated gastric lesions after eradication therapy","volume":"57","author":"Nakagawa","year":"2018","journal-title":"Intern Med Tokyo Jpn"},{"issue":"9","key":"10.1016\/j.ajg.2024.11.002_b0150","first-page":"799","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"44","author":"Mesnard","year":"2012","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"9","key":"10.1016\/j.ajg.2024.11.002_b0155","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.intimp.2004.05.011","article-title":"Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL","volume":"4","author":"Mizunoe","year":"2004","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.ajg.2024.11.002_b0160","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1038\/srep07438","article-title":"Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity","volume":"11","author":"Ratzinger","year":"2014","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ajg.2024.11.002_b0165","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/annonc\/mdv214","article-title":"High-dose clarithromycin is an active monotherapy for patients with relapsed\/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial","volume":"26","author":"Ferreri","year":"2015","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197924001072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197924001072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T03:38:36Z","timestamp":1741837116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197924001072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1687197924001072"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2024.11.002","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and temporal trends in H. pylori negative gastric maltoma","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2024.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}